Yin Xintian
Director-General of Legal Affairs Department
State Intellectual Property Office

Feng Yi
Director of Centerof Drug Evaluation
SFDA

Dai Haosen
Chairman
Novartis China

Peter Huang
Principal
BCG

Suzana Nahum zilberberg
VP Asia, International Group
Teva Pharmaceutical Industries Ltd.

James He
Head of Asia
Amgen

Dr. Jeff Davies
General Manager-Asia Pacific
CSL Bioplasma

Yao Yifei
Technical Director
Alcan Packaging Pharmaceutical

Wang Xuetao
Director,Department of Drug Policies and Essential Drug Policy
Ministry of Health

Tao Jianhong
Deputy Director, Institute of Southern Medical Economy Research
SFDA

Zhang Ruoming
Center for Drug Evaluation
SFDA

Wang Jinxia
Secretary General
China Association of Pharmaceutical Commerce

Bai Huiliang
Vice Chairman
China Nonprescription Medicines Association

Zhang Qingkui
Director General of Patent Examination Cooperate Center
State Intellectual Property Office

Zhang Junze
Deputy Director, National Center for ADR Monitoring
SFDA

Liu Min
Deputy Director, Marketing Research Center
State Administration for Industry & Commerce

Liang Xiaofeng
Director General
Department for Immunization Program Chinese Center for Disease Control and Prevention

Huo Yan
National Center for Safety Evaluation of Drugs
National Institute for the Control of Pharmaceutical and Biological Products

Michel Baijot
Vice President of WW Business Development and Strategic Alliances
GSK

Eric Zhang
Senior Product Manager
Pfizer

Robert Pollard
Director, Healthcare of China
Synovate

Zhang Xuemei
Director
Changchun Institute of Biological Products Influenza Vaccine

Sam Williamson
Life Science Operations Director
M+W Zander

Feng Keting
Product Manager
Siemens